• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体靶向的磷酸钙硅纳米颗粒优先被共培养的人转移性乳腺癌细胞和骨成骨细胞中的转移性三阴性乳腺癌细胞摄取。

Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteoblasts.

机构信息

Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA.

Department of Bioengineering, The Pennsylvania State University, University Park, PA.

出版信息

Nanomedicine. 2021 Jun;34:102383. doi: 10.1016/j.nano.2021.102383. Epub 2021 Mar 13.

DOI:10.1016/j.nano.2021.102383
PMID:33722692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8627646/
Abstract

Calcium phosphosilicate nanoparticles (CPSNPs) are bioresorbable nanoparticles that can be bioconjugated with targeting molecules and encapsulate active agents and deliver them to tumor cells without causing damage to adjacent healthy tissue. Data obtained in this study demonstrated that an anti-CD71 antibody on CPSNPs targets these nanoparticles and enhances their internalization by triple negative breast cancer cells in-vitro. Caspase 3,7 activation, DNA damage, and fluorescent microscopy confirmed the apoptotic breast cancer response caused by targeted anti-CD71-CPSNPs encapsulated with gemcitabine monophosphate, the active metabolite of the chemotherapeutic gemcitabine used to treat cancers including breast and ovarian. Targeted anti-CD71-CPSNPs encapsulated with the fluorophore, Rhodamine WT, were preferentially internalized by breast cancer cells in co-cultures with osteoblasts. While osteoblasts partially internalized anti-CD71-GemMP-CPSNPs, their cell growth was not affected. These results suggest that CPSNPs may be used as imaging tools and selective drug delivery systems for breast cancer that has metastasized to bone.

摘要

钙磷硅纳米颗粒(CPSNPs)是一种可生物吸收的纳米颗粒,可与靶向分子进行生物偶联,并将活性药物包裹其中递送至肿瘤细胞,而不会对邻近的健康组织造成损害。本研究获得的数据表明,CPSNPs 上的抗 CD71 抗体靶向这些纳米颗粒,并增强其在体外三阴性乳腺癌细胞中的内化作用。半胱天冬酶 3、7 激活、DNA 损伤和荧光显微镜证实了由靶向抗 CD71-CPSNPs 包裹的吉西他滨单磷酸盐(用于治疗包括乳腺癌和卵巢癌在内的癌症的化疗药物吉西他滨的活性代谢物)引起的乳腺癌细胞凋亡反应。与成骨细胞共培养时,带有荧光染料 Rhodamine WT 的靶向抗 CD71-CPSNPs 优先被乳腺癌细胞内化。虽然成骨细胞部分内化了抗 CD71-GemMP-CPSNPs,但它们的细胞生长不受影响。这些结果表明,CPSNPs 可作为成像工具和用于治疗转移至骨骼的乳腺癌的选择性药物递送系统。

相似文献

1
Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteoblasts.抗体靶向的磷酸钙硅纳米颗粒优先被共培养的人转移性乳腺癌细胞和骨成骨细胞中的转移性三阴性乳腺癌细胞摄取。
Nanomedicine. 2021 Jun;34:102383. doi: 10.1016/j.nano.2021.102383. Epub 2021 Mar 13.
2
Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancer.磷酸化化疗药物在磷酸钙硅纳米粒子中的有效包封及其用于胰腺癌治疗的生物学活性。
Nanomedicine. 2017 Oct;13(7):2313-2324. doi: 10.1016/j.nano.2017.06.017. Epub 2017 Jul 1.
3
Targeted indocyanine-green-loaded calcium phosphosilicate nanoparticles for in vivo photodynamic therapy of leukemia.载靶向吲哚菁绿的磷酸钙硅纳米粒用于白血病的体内光动力治疗。
ACS Nano. 2011 Jul 26;5(7):5325-37. doi: 10.1021/nn2005766. Epub 2011 Jul 8.
4
Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo.钙磷硅复合纳米颗粒的生物偶联用于体内选择性靶向人乳腺癌和胰腺癌。
ACS Nano. 2010 Mar 23;4(3):1279-87. doi: 10.1021/nn901297q.
5
miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.miRNA-30 家族成员通过直接靶向多个骨转移相关基因抑制乳腺癌的侵袭、成骨样表型和骨质破坏。
Cancer Res. 2018 Sep 15;78(18):5259-5273. doi: 10.1158/0008-5472.CAN-17-3058. Epub 2018 Jul 24.
6
Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancer.模拟 HDL 纳米颗粒:一种针对三阴性乳腺癌的新型药物递送策略。
Surgery. 2019 Dec;166(6):1168-1175. doi: 10.1016/j.surg.2019.06.010. Epub 2019 Jul 29.
7
Nanoparticles target early-stage breast cancer metastasis in vivo.纳米颗粒在体内靶向早期乳腺癌转移。
Nanotechnology. 2017 Oct 27;28(43):43LT01. doi: 10.1088/1361-6528/aa8a3d. Epub 2017 Sep 5.
8
Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.负载氨基黄酮的表皮生长因子受体靶向单分子胶束纳米颗粒在三阴性乳腺癌中显示出抗癌作用。
Biomaterials. 2016 Sep;101:20-31. doi: 10.1016/j.biomaterials.2016.05.041. Epub 2016 May 27.
9
Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer.纳米颗粒介导的 Notch-1 抗体和 ABT-737 的共递送作为三阴性乳腺癌的有效治疗策略。
ACS Nano. 2020 Mar 24;14(3):3378-3388. doi: 10.1021/acsnano.9b09263. Epub 2020 Feb 26.
10
In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.整合素 α5 靶向纳米递药策略抑制体内 β-连环蛋白衰减,从而抑制三阴性乳腺癌干细胞特性和转移。
Biomaterials. 2019 Jan;188:160-172. doi: 10.1016/j.biomaterials.2018.10.019. Epub 2018 Oct 18.

引用本文的文献

1
Nanotheranostics in Breast Cancer Bone Metastasis: Advanced Research Progress and Future Perspectives.纳米诊疗学在乳腺癌骨转移中的应用:前沿研究进展与未来展望
Pharmaceutics. 2024 Nov 21;16(12):1491. doi: 10.3390/pharmaceutics16121491.
2
Analytical Techniques for Characterizing Tumor-Targeted Antibody-Functionalized Nanoparticles.用于表征肿瘤靶向抗体功能化纳米颗粒的分析技术
Life (Basel). 2024 Apr 10;14(4):489. doi: 10.3390/life14040489.
3
Nanoparticles for the Treatment of Bone Metastasis in Breast Cancer: Recent Advances and Challenges.用于治疗乳腺癌骨转移的纳米粒子:最新进展与挑战。
Int J Nanomedicine. 2024 Feb 23;19:1867-1886. doi: 10.2147/IJN.S442768. eCollection 2024.

本文引用的文献

1
Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease.纳米颗粒介导的药物递送用于治疗缺血性心脏病
Front Bioeng Biotechnol. 2020 Jun 24;8:687. doi: 10.3389/fbioe.2020.00687. eCollection 2020.
2
Triple-negative breast cancer molecular subtyping and treatment progress.三阴性乳腺癌分子分型及治疗进展。
Breast Cancer Res. 2020 Jun 9;22(1):61. doi: 10.1186/s13058-020-01296-5.
3
Molecular subtypes and precision treatment of triple-negative breast cancer.三阴性乳腺癌的分子亚型与精准治疗
Ann Transl Med. 2020 Apr;8(7):499. doi: 10.21037/atm.2020.03.194.
4
Intercalary Reconstruction of the "Ultra-Critical Sized Bone Defect" by 3D-Printed Porous Prosthesis After Resection of Tibial Malignant Tumor.胫骨恶性肿瘤切除术后3D打印多孔假体对“超临界尺寸骨缺损”的间置重建
Cancer Manag Res. 2020 Apr 8;12:2503-2512. doi: 10.2147/CMAR.S245949. eCollection 2020.
5
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
6
ER+ metastatic breast cancer: past, present, and a prescription for an apoptosis-targeted future.雌激素受体阳性转移性乳腺癌:过去、现在以及针对细胞凋亡的未来治疗方案
Am J Cancer Res. 2019 Dec 1;9(12):2821-2831. eCollection 2019.
7
Monoclonal antibody-based molecular imaging strategies and theranostic opportunities.基于单克隆抗体的分子成像策略与治疗机会。
Theranostics. 2020 Jan 1;10(2):938-955. doi: 10.7150/thno.37443. eCollection 2020.
8
Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer.多西他赛联合洛铂或吉西他滨治疗复发转移性乳腺癌的初步研究
Medicine (Baltimore). 2019 Dec;98(52):e18513. doi: 10.1097/MD.0000000000018513.
9
Smart Targeting To Improve Cancer Therapeutics.智能靶向以改善癌症治疗
Drug Des Devel Ther. 2019 Oct 30;13:3753-3772. doi: 10.2147/DDDT.S219489. eCollection 2019.
10
Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling.转铁蛋白受体 2 通过 BMP 和 Wnt 信号通路控制骨量和病理性骨形成。
Nat Metab. 2019 Jan;1(1):111-124. doi: 10.1038/s42255-018-0005-8. Epub 2019 Jan 7.